Corvus Pharmaceuticals (CRVS) Cost of Revenue (2025 - 2026)
Corvus Pharmaceuticals (CRVS) recorded quarterly Cost of Revenue of $1.9 million in Q1 2026, up 102.74% quarter-over-quarter from $949000.0 in Q1 2025, and up 102.74% on a YoY basis from $949000.0 in Q1 2025.
Corvus Pharmaceuticals (CRVS) Cost of Revenue (2025 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Cost of Revenue history runs 2 years deep, the most recent figure standing at $1.9 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 2.05 Mn |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - | 1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.92 Mn |
| Mar 31, 2026 | 1.92 Mn |
| Mar 31, 2025 | 949,000.00 |
| Mar 31, 2025 | 949,000.00 |